That's the conclusion of British researchers, who looked at data on more than 9,000 men and found that the taller they come, the higher the prostate cancer risk, and the better the odds that the cancer will be a more serious high-grade form.
Compared with other risk factors for prostate cancer, such as age and race, being height-advantaged adds only slightly to a man's chances of developing the disease.
Some of the factors that make men tall may also raise their prostatecancer risk, says researcher Luisa Zuccolo, MSc, a PhD candidate in the department of social medicine at Bristol University in England.
"A better growth, and possibly a more rapid growth, we find associated with a very modest increase in risk of prostate cancer and a slightly greater risk of more progressive disease," Zuccolo tells WebMD.
The study should not, however, be cause for concern among the altitudinally gifted, says Anthony D'Amico, MD, PhD, chief of genitourinary radiation oncology at the Brigham & Women's Hospital and Dana-Farber Cancer Institute in Boston.
"My bottom line on this study right now is that it's very interesting, but it's not in my opinion ready to act on in terms of clinical implications," D'Amico tells WebMD. "In other words, I don't think we should screen people who are taller at a younger age, because I don't think the level of evidence is strong enough to support that taller people are more likely to get high-grade cancers."
The researchers speculate that levels of a hormone known as insulin-like growth factor-I (IGF-1) in childhood may play a role in cancer risk. Taller men tend to have had higher blood levels of IGF-1 in childhood, and higher blood levels of the growth factor in adulthood have been linked to higher prostate cancer risk.